Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • LOW vs MRNA✓SelectedUSD · MRNALOW vs MRNA performance historyLatest closeAs of+0.78%11/20
Stock and ETF performance explorer

LOW vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+14.8%
MRNA return
+153.9%
Excess return
-139.2%
Maximum drawdown
-36.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+0.8%-2.2%+2.9%+0.8%
7D-3.0%-12.7%+9.7%-2.7%
30D+12.4%-20.7%+33.0%+13.0%
3M+2.3%+46.3%-44.0%+0.9%
6M+1.2%+305.2%-304.1%-6.6%
YTD-6.4%+561.2%-567.7%-17.1%
1Y-1.2%+772.1%-773.3%-14.5%
3Y+14.8%+147.0%-132.2%-2.9%
All+14.8%+153.9%-139.2%-2.9%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling